反応式
[Cl:1][C:2]1[CH:3]=[C:4]([CH:8]=[C:9]([O:11][CH3:12])[N:10]=1)[C:5]([OH:7])=O.[F:13][C:14]1[CH:15]=[C:16]2[C:20](=[CH:21][CH:22]=1)[NH:19][CH2:18][CH2:17]2.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F>CN(C=O)C>[Cl:1][C:2]1[CH:3]=[C:4]([C:5]([N:19]2[C:20]3[C:16](=[CH:15][C:14]([F:13])=[CH:22][CH:21]=3)[CH2:17][CH2:18]2)=[O:7])[CH:8]=[C:9]([O:11][CH3:12])[N:10]=1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
0.50 g (2.7 mmol) 2-chloro-6-methoxyisonicotinic acid, 0.37 g (2.7 mmol) 5-fluoroindoline and 0.42 mL (3 mmol) TEA were in 10 mL DMF placed. 0.97 g (3.0 mmol) TBTU were added and the reaction mixture was 2 h stirred at RT. The substance was purified by HPLC. The product-containing fractions were combined and freeze-dried.
後処理
- customThe substance was purified by HPLC
- customfreeze-dried
出典と根拠
- ORDレコード
- ord-2aaf8833422d4f5c929e77143a2dbfe9
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08829006B2
関連ノート
読み込み中…